BIOTON S.A. (WSE: BIO)

Poland flag Poland · Delayed Price · Currency is PLN
3.565
+0.045 (1.28%)
Jan 21, 2025, 5:00 PM CET
1.28%
Market Cap 306.11M
Revenue (ttm) 177.60M
Net Income (ttm) -5.80M
Shares Out 85.86M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 31,896
Average Volume 78,708
Open 3.510
Previous Close 3.520
Day's Range 3.510 - 3.570
52-Week Range 2.795 - 3.775
Beta 0.15
RSI 73.15
Earnings Date Mar 28, 2025

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 359
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

In 2023, BIOTON's revenue was 181.64 million, a decrease of -22.10% compared to the previous year's 233.16 million. Earnings were 2.28 million, an increase of 60.10%.

Financial Statements

News

There is no news available yet.